Zobrazeno 1 - 10
of 153
pro vyhledávání: '"J.P., Cazenave"'
Publikováno v:
Transfusion Clinique et Biologique. 22:225-226
Objectifs Les objectifs sont : – d’analyser le risque residuel transfusionnel du VIH au CNTS de Lome (Togo) ; – de proposer les orientations futures pour renforcer la securite transfusionnelle. Methodologie Le risque residuel a ete estime chez
Autor:
Edith Fressinaud, M. E. Briquel, M. Alcalay, N. Stieltjes, J. Fonlupt, J.P. Cazenave, C. Guerois, Claude Negrier, A. Parquet, Roseline d'Oiron, J. Goudemand
Publikováno v:
Vox Sanguinis. 67:9-13
The prevalence of serum antibodies to hepatitis A virus (HAV) in 793 hemophilia A (HA) and 89 hemophilia B (HB) patients coming from 10 French Hemophilia Centers and treated since 1986-1987 with solvent/detergent (SD)-treated products is reported. Th
Publikováno v:
Journal of Biological Chemistry. 268:20801-20807
Glycoprotein V (GPV) is a major platelet membrane 82-kDa glycoprotein, missing in the Bernard-Soulier syndrome, that is cleaved when platelets are treated with thrombin. We report the cloning and sequencing of the GPV cDNA and gene obtained by a comb
Publikováno v:
Journal of Dispersion Science and Technology. 13:379-398
Reversible and irreversible aspects of polyclonal IgG adsorption onto glass beads were studied using 125I radiolabeled proteins for bulk concentrations as low as 4× 10−4 mg ml−1. A true thermodynamic equilibrium was reached in the low bulk conce
Autor:
J.L. Wautier, J.P. Cazenave
Publikováno v:
Transfusion Clinique et Biologique. 7:332-334
Autor:
A. Faradji, A. Bohbot, J. Damonte, J.P. Arnaud, M. Eber, D. Laustriat, J. Goetz, M.L. Wiesel, G. Follea, Y. Piemont, J.P. Bergerat, J.P. Cazenave, M. Adloff, F. Oberling
Publikováno v:
The International Journal of Artificial Organs. 14:109-115
To evaluate the safety of on-line plasma perfusion over protein-A sepharose and the therapeutic advantage of combining plasma perfusion (PP) over protein-A sepharose with 5-fluorouracil (5-FU) chemotherapy in patients with metastatic colorectal carci
Autor:
La Salle H., De, Mariotti, S., Angenieux, C., Gilleron, M., L.-F., Garcia-Alles, Maître, B., Malm, D., Berg, T., Mourey, L., Salamero, J., J.P., Cazenave, Hanau, D., Mori, L., Puzo, G., Libero G., De
Publikováno v:
Science
Science, American Association for the Advancement of Science, 2005, 310 (5752), pp.1321-1324
Science, American Association for the Advancement of Science, 2005, 310 (5752), pp.1321-1324
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ebcae4377053a2c9945ece7bd9aedc24
https://hal.archives-ouvertes.fr/hal-00077256
https://hal.archives-ouvertes.fr/hal-00077256
Publikováno v:
The Journal of biological chemistry
The Journal of biological chemistry, 1993, 268 (1), pp.421-429
Alain Beretz
Scopus-Elsevier
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 1993, 268 (1), pp.421-429
Europe PubMed Central
The Journal of biological chemistry, 1993, 268 (1), pp.421-429
Alain Beretz
Scopus-Elsevier
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 1993, 268 (1), pp.421-429
Europe PubMed Central
The effects of thrombin, D-phenylalanyl-L-propyl-L-arginine chloromethyl ketone (PPACK)-inhibited thrombin, and thrombin receptor agonist peptide, SFLLRNPNDKYEPF (SFLL, a portion of the receptor unmasked after thrombin cleavage), on the expression of
Publikováno v:
Atherosclerosis Supplements. 2:132-133
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.